D. E. Shaw & Co., Inc. Sarepta Therapeutics, Inc. Call Options Transaction History

D. E. Shaw & Co., Inc.

13 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $757,099 - $1.19 Million	10,000 New	10,000 $1.11 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $186,000 - $343,400	-2,000 Reduced 16.67%	10,000 $1.6 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $4.75 Million - $7.6 Million	-57,700 Reduced 82.78%	12,000 $1.17 Million
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $107,142 - $189,812	-1,400 Reduced 1.97%	69,700 $8.99 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $728,100 - $1.57 Million	10,000 Added 16.37%	71,100 $5.36 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $2.24 Million - $3.04 Million	-20,000 Reduced 24.66%	61,100 $9.28 Million
Q1 2019 May 15, 2019	SELL	$106.67 - $151.68 $6.93 Million - $9.86 Million	-65,000 Reduced 44.49%	81,100 $9.67 Million
Q4 2018 Feb 14, 2019	BUY	$97.32 - $148.76 $973,199 - $1.49 Million	10,000 Added 7.35%	146,100 $15.9 Million
Q3 2018 Nov 14, 2018	BUY	$115.31 - $161.51 $4.72 Million - $6.61 Million	40,900 Added 42.96%	136,100 $22 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $2.53 Million - $5.41 Million	35,200 Added 58.67%	95,200 $12.6 Million
Q1 2018 May 15, 2018	BUY	$54.02 - $82.27 $189,070 - $287,945	3,500 Added 6.19%	60,000 $4.45 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $476,400 - $567,500	10,000 Added 21.51%	56,500 $3.14 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $1.66 Million - $2.19 Million	46,500	46,500 $2.11 Million

529

84.2M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.4B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.